2026 witnesses a comprehensive paradigm shift in global medicine, with the medical model gradually transforming from the traditional “disease-centered” passive
Neurological diseases, represented by multiple sclerosis (MS) and neurodegenerative disorders, have long been difficult clinical problems due to their complex
New drug research and development is characterized by long cycle, high cost and high risk, which makes it difficult for
The human gut microbiome, known as the “second genome”, plays a core regulatory role in human metabolism, immunity, nervous system
